Sökresultat - Shanthakumar Tyavanagimatt

  • Visas 1 - 9 av 9 resultat
Förfina resultatet
  1. 1
    Development of ST-246® for Treatment of Poxvirus Infections

    Development of ST-246® for Treatment of Poxvirus Infections av Robert Jordan, Janet M. Leeds, Shanthakumar Tyavanagimatt, Dennis E. Hruby

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor av Robert Jordan, Deborah Tien, Tové C. Bolken, Kevin F. Jones, Shanthakumar Tyavanagimatt, Josef Strasser, Annie Frimm, Michael L. Corrado, Phoebe G. Strome, Dennis E. Hruby

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    A potent Lassa virus antiviral targets an arenavirus virulence determinant

    A potent Lassa virus antiviral targets an arenavirus virulence determinant av Ikenna G. Madu, Megan Files, Dima Gharaibeh, Amy L. Moore, Kie-Hoon Jung, Brian B. Gowen, Dongcheng Dai, Kevin F. Jones, Shanthakumar Tyavanagimatt, James R. Burgeson, Marcus J. Korth, Kristin Bedard, Shawn P. Iadonato, Sean M. Amberg

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein av Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach, Aklile Berhanu, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Kristin A. Wineinger, Jessica Pagé, Chris Harver, Eric Stavale, Shanthakumar Tyavanagimatt, Melialani A. Stone, Ralf Bartenschlager, Pietro Scaturro, Dennis E. Hruby, Robert Jordan

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers av Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis av Stephen T. Oh, Ruben A. Mesa, Claire Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean‐Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah Buckley, Shanthakumar Tyavanagimatt, Bryan Harder, Karisse Roman‐Torres, Jennifer A. Smith, Adam R. Craig, John Mascarenhas, Srđan Verstovšek

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification av Robert Jordan, Arthur J. Goff, Annie Frimm, Michael L. Corrado, Lisa E. Hensley, Chelsea M. Byrd, Eric M. Mucker, Josh Shamblin, Tové C. Bolken, Carly Wlazlowski, Wendy Johnson, Jennifer Chapman, Nancy Twenhafel, Shanthakumar Tyavanagimatt, Adams Amantana, Jarasvech Chinsangaram, Dennis E. Hruby, John W. Huggins

    Publicerad 2009
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase av Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, Chris Harver, Kristin A. Wineinger, Jessica Pagé, Eric Stavale, Melialani A. Stone, Kathleen Fuller, Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis av Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklós Egyed, Claire Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jean‐Jacques Kiladjian, Jennifer O’Sullivan, Valentín García‐Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman‐Torres, Sri Devineni, Adam R. Craig, John Mascarenhas

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: